Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

785 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A Retrospective Study of Cemiplimab Effectiveness in Elderly Patients with Squamous Cell Carcinoma of the Skin: Insights from a Real-Life Scenario.
Di Lorenzo G, Michele A, Silvana L, Bilancia D, Di Trolio R, Iuliucci MR, Ingenito C, Rubino R, Piscosquito A, Caraglia M, Donnarumma M, Costabile F, Conca R, Pisino M, Vaia A, Scafuri L, Verde A, Buonerba C. Di Lorenzo G, et al. Among authors: di trolio r. Oncol Ther. 2024 Mar;12(1):147-155. doi: 10.1007/s40487-023-00256-1. Epub 2023 Dec 19. Oncol Ther. 2024. PMID: 38112965 Free PMC article.
PREVES: A Population-Based Survey Focused on Cancer and Nutrition.
Di Lorenzo G, Ingenito C, Iervolino M, Sosto G, Sergianni P, Primiano F, Piscosquito A, Iuliucci MR, Rubino R, Gatani S, Ugliano F, Scafuri L, Costabile F, D'Ambrosio B, D'Antonio A, Crescenzo A, Cappuccio F, Buonerba C. Di Lorenzo G, et al. Oncology. 2023;101(6):369-374. doi: 10.1159/000530626. Epub 2023 Apr 13. Oncology. 2023. PMID: 37054688 Free article.
Comparing cardiovascular adverse events in cancer patients: A meta-analysis of combination therapy with angiogenesis inhibitors and immune checkpoint inhibitors versus angiogenesis inhibitors alone.
Crocetto F, Ferro M, Buonerba C, Bardi L, Dolce P, Scafuri L, Mirto BF, Verde A, Sciarra A, Barone B, Calogero A, Sagnelli C, Busetto GM, Del Giudice F, Cilio S, Sonpavde G, Di Trolio R, Della Ratta GL, Barbato G, Di Lorenzo G. Crocetto F, et al. Among authors: di trolio r, di lorenzo g. Crit Rev Oncol Hematol. 2023 Aug;188:104059. doi: 10.1016/j.critrevonc.2023.104059. Epub 2023 Jun 21. Crit Rev Oncol Hematol. 2023. PMID: 37353178 Review.
Predictors of Efficacy of Immune Checkpoint Inhibitors in Patients With Advanced Urothelial Carcinoma: A Systematic Review and Meta-Analysis.
Ferro M, Crocetto F, Tataru S, Barone B, Dolce P, Lucarelli G, Sonpavde G, Musi G, Antonelli A, Veccia A, Terracciano D, Busetto GM, Del Giudice F, Marchioni M, Schips L, Porpiglia F, Fiori C, Carrieri G, Lasorsa F, Verde A, Scafuri L, Buonerba C, Di Lorenzo G. Ferro M, et al. Among authors: di lorenzo g. Clin Genitourin Cancer. 2023 Oct;21(5):574-583. doi: 10.1016/j.clgc.2023.05.017. Epub 2023 May 27. Clin Genitourin Cancer. 2023. PMID: 37419854
Instant Messaging in Cancer Care.
Buonerba C, Calabrese AN, Imperioso G, Piscosquito A, Verde A, Vaia A, Scafuri L, Crocetto F, Leopardo D, Rocco B, Del Giudice F, Tufano A, Casale B, Cappuccio F, Chiancone F, Di Trolio R, Di Lorenzo G. Buonerba C, et al. Among authors: di trolio r, di lorenzo g. Oncology. 2024;102(8):659-662. doi: 10.1159/000536345. Epub 2024 Jan 23. Oncology. 2024. PMID: 38262385 Free article. No abstract available.
Unraveling the Dietary Puzzle: Exploring the Influence of Diet, Nutraceuticals, and Supplements on Bladder Cancer Risk, Outcomes, and Immunotherapy Efficacy: Insights from the BLOSSOM Study and Beyond.
Buonerba C, Ingenito C, Di Trolio R, Cappuccio F, Rubino R, Piscosquito A, Verde A, Costabile F, Iuliucci M, Crocetto F, Chiancone F, Nacchia A, Campitelli A, Scafuri L, Sanseverino R, Di Lorenzo G. Buonerba C, et al. Among authors: di trolio r, di lorenzo g. Oncol Ther. 2024 Jun;12(2):189-195. doi: 10.1007/s40487-024-00266-7. Epub 2024 Feb 28. Oncol Ther. 2024. PMID: 38416326 Free PMC article.
Gender minorities in breast cancer - Clinical trials enrollment disparities: Focus on male, transgender and gender diverse patients.
Miglietta F, Pontolillo L, De Angelis C, Caputo R, Marino M, Bria E, Di Rienzo R, Verrazzo A, Buonerba C, Tortora G, Di Lorenzo G, Del Mastro L, Giuliano M, Montemurro F, Puglisi F, Guarneri V, De Laurentiis M, Scafuri L, Arpino G. Miglietta F, et al. Among authors: di lorenzo g, di rienzo r. Breast. 2024 Jun;75:103713. doi: 10.1016/j.breast.2024.103713. Epub 2024 Mar 9. Breast. 2024. PMID: 38493590 Free PMC article. Review.
Exploring a Novel Approach to Spare Classic Chemotherapy in HER2-Low, ER-Positive Breast Cancer Based on Trastuzumab Deruxtecan Combined with Endocrine Therapy.
Scafuri L, Buonerba C, Di Lauro V, Tortora V, Cascella M, Liguori L, Sciarra A, Sabbatino F, Diana A, Marra A, Tarantino P, Trapani D, Giuliano M, Arpino G, Curigliano G, Di Lorenzo G. Scafuri L, et al. Among authors: di lorenzo g, di lauro v. Oncol Ther. 2024 Sep;12(3):363-373. doi: 10.1007/s40487-024-00286-3. Epub 2024 Jun 28. Oncol Ther. 2024. PMID: 38941050 Free PMC article.
785 results